LncRNA-miRNA interaction is involved in colorectal cancer pathogenesis by modulating diverse signaling pathways

Shadia Hamoud Alshahrani1, Zeina S M Al-Hadeithi2, Sami G Almalki3

  • 1Medical Surgical Nursing Department, King Khalid University, Khamis Mushate, Saudi Arabia.

PubMed

Insights

Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) regulate cancer genes. Targeting their interaction shows promise for colorectal cancer (CRC) treatment, but challenges like specificity and delivery need addressing.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Long non-coding RNAs (lncRNAs) act as molecular sponges or directly interact with microRNAs (miRNAs).
  • MicroRNAs (miRNAs) are crucial regulators of gene expression, including oncogenes and tumor suppressor genes.
  • Dysregulation of miRNAs is implicated in the development and progression of various cancers, including colorectal cancer (CRC).

Purpose of the Study:

  • To explore the therapeutic potential of targeting the lncRNA-miRNA axis in colorectal cancer (CRC).
  • To identify key challenges hindering the clinical application of lncRNA-miRNA-based therapies for CRC.

Main Methods:

  • The study reviews the mechanisms by which lncRNAs and miRNAs interact and influence gene expression.
  • It analyzes the role of the lncRNA-miRNA axis in the context of cancer-related genes and CRC pathogenesis.
  • The research synthesizes current knowledge on therapeutic strategies targeting this axis.

Main Results:

  • LncRNAs can modulate miRNA activity through sponging or direct interaction, impacting cancer-related gene expression.
  • miRNA dysregulation is a significant factor in CRC onset and progression.
  • Targeting the lncRNA-miRNA axis presents a promising avenue for CRC treatment.

Conclusions:

  • The lncRNA-miRNA axis holds significant therapeutic potential for colorectal cancer (CRC).
  • Overcoming challenges related to targeting specificity, delivery, resistance, safety, and cost-effectiveness is crucial for clinical translation.
  • Further research is needed to optimize these strategies for improved CRC patient outcomes.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K